Development and validation of an indirect pulsed electrochemical detection method for monitoring the inhibition of Abl1 tyrosine kinase

J Pharm Biomed Anal. 2014 Mar:90:52-7. doi: 10.1016/j.jpba.2013.11.022. Epub 2013 Nov 27.

Abstract

A new method for monitoring the enzyme inhibition of Abl1 tyrosine kinase by liquid chromatography-indirect pulsed electrochemical detection (LC-InPED) was developed. In this method, adsorption of a peptide analyte at the noble metal electrode suppresses the oxidation of polyols under alkaline condition to elicit an indirect response resulting in a negative peak of the target peptide. Among the reagents tested, D-gluconic acid sodium salt gave the best overall signal to noise (S/N) values for the indirect detection of p-Abltide, the product of Abl1 enzymatic reaction. 50 μM D-gluconic acid sodium salt dissolved in a mixture of 78% water-22% acetonitrile-0.03% trifluoroacetic acid (TFA) was used as the mobile phase. Chromatographic separation was achieved on an Alltima C18 (I.D. 5 μm; 250 mm × 4.6 mm) column with the mobile phase flow rate of 0.5 ml/min. 0.5M sodium hydroxide was added post-column to maintain alkaline conditions in the PED cell. The limit of quantification (LOQ) was 0.2 μM for p-Abltide, which was about 50-fold lower than direct PED analysis. The residual plot of the linear calibration curve indicated a good fit with a linear model within the investigated concentration range of p-Abltide. Intra- and inter-day precision was not more than 6.5% and accuracy was from -5.75% to +1.54%. The validated LC-InPED method was successfully applied for monitoring of p-Abltide in Abl1 enzyme reaction and the inhibition study of Abl1. The determined IC50 values of model inhibitors, imatinib, nilotinib and dasatinib, were 601.4 nM (R(2)=0.99), 32.3 nM (R(2)=0.99) and 1.3 nM (R(2)=0.98), respectively. These results were consistent with literature data. To the best of our knowledge this is the first time a LC-InPED method has been used to monitor an enzyme reaction.

Keywords: Abl1 tyrosine kinase; Abltide; Inhibition assay; LC–InPED.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Benzamides / administration & dosage
  • Benzamides / pharmacology
  • Calibration
  • Chromatography, Liquid / methods*
  • Dasatinib
  • Electrochemical Techniques / methods*
  • Fusion Proteins, bcr-abl / antagonists & inhibitors*
  • Gluconates / chemistry
  • Imatinib Mesylate
  • Inhibitory Concentration 50
  • Limit of Detection
  • Linear Models
  • Piperazines / administration & dosage
  • Piperazines / pharmacology
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / pharmacology*
  • Pyrimidines / administration & dosage
  • Pyrimidines / pharmacology
  • Thiazoles / administration & dosage
  • Thiazoles / pharmacology

Substances

  • BCR-ABL1 fusion protein, human
  • Benzamides
  • Gluconates
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Imatinib Mesylate
  • Fusion Proteins, bcr-abl
  • nilotinib
  • gluconic acid
  • Dasatinib